Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 4, 2015
Fate of fenestration in children treated with fontan operationJaana I Pihkala, Merit Järvelä, Talvikki Boldt, et al.
Molecular Cancer Therapeutics|July 27, 2016
Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive CancerIlkka Liikanen, Siri Tähtinen, Kilian Guse, et al.
Molecular Therapy Oncolytics|July 11, 2018
Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic ImmunotherapyOtto Hemminki, Minna Oksanen, Kristian Taipale, et al.
Journal of Translational Medicine|August 23, 2013
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatmentMari Hirvinen, Raita Heiskanen, Minna Oksanen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 11, 2014
Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumorsAnna Kanerva, Anniina Koski, Ilkka Liikanen, et al.
Oncoimmunology|May 8, 2015
Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapyIlkka Liikanen, Anniina Koski, Maiju Merisalo-Soikkeli, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 3, 2011
Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancerAnniina Koski, Mari Raki, Petri Nokisalmi, et al.
Oncotarget|February 22, 2018
Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patientsKristian Taipale, Siri Tähtinen, Riikka Havunen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2016
Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic ImmunotherapyKristian Taipale, Ilkka Liikanen, Anniina Koski, et al.
Oncoimmunology|April 9, 2016
Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancerSimona Bramante, Anniina Koski, Ilkka Liikanen, et al.
Pageof 3